Correction to: Effect of Empagliflozin as an Add-On Therapy on Decongestion and Renal Function in Patients With Diabetes Hospitalized for Acute Decompensated Heart Failure: A Prospective Randomized Controlled Study

In the article by Tamaki et al, “Effect of Empagliflozin as an Add-On Therapy on Decongestion and Renal Function in Patients With Diabetes Hospitalized for Acute Decompensated Heart Failure: A Prospective Randomized Controlled Study,” which published online on March 5, 2021 and appeared in the March 2021 issue of the journal (Circ Heart Fail. 2021;14:e007048), a correction is needed.

Due to a production error, reference 20 was incorrect in the original publication. The correct reference is: Kondo T, Yamada T, Tamaki S, Morita T, Furukawa Y, Iwasaki Y, Kawasaki M, Kikuchi A, Ozaki T, Sato Y, et al. Serial change in serum chloride during hospitalization could predict heart failure death in acute decompensated heart failure patients. Circ J. 2018;82:1041–1050. doi: 10.1253/circj.CJ-17-0938.

This correction has been made to the current version of the article, which is available at https://www.ahajournals.org/doi/10.1161/CIRCHEARTFAILURE.120.007048